Mark A. Schroeder
Impact in
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
- Hematology 89
- Hematopoietic Stem Cell Transplantation 54
- Acute Myeloid Leukemia Research 30
- Multiple Myeloma Research and Treatments 24
- Chronic Myeloid Leukemia Treatments 12
- Genetics 43
- Glioma Diagnosis and Treatment 23
- Co-authors
- Jann Nagina Sarkaria (42 shared papers)Brett L. Carlson (30 shared papers)John F. DiPersio (62 shared papers)Mark S. Wrighton (7 shared papers)Charles David James (11 shared papers)Rolf D. Hubmayr (5 shared papers)Nicholas E. Vlahakis (4 shared papers)Evanthia Galanis (15 shared papers)
- Journals
- Transplantation and Cellular Therapy (25 papers)Blood (21 papers)Clinical Cancer Research (10 papers)Bone Marrow Transplantation (9 papers)Neuro-Oncology (5 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Mark A. Schroeder
194 papers receiving 7.0k citations
Peers
Comparison fields: 5 of 161
- Genetics 1.5k
- Hematology 1.4k
- Oncology 1.7k
- Immunology 1.1k
- Cancer Research 615
Countries citing papers authored by Mark A. Schroeder
This map shows the geographic impact of Mark A. Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Schroeder more than expected).
Fields of papers citing papers by Mark A. Schroeder
This network shows the impact of papers produced by Mark A. Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Schroeder. The network helps show where Mark A. Schroeder may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Schroeder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 332 | |
| 2 | 2008 | 315 | |
| 3 | 2005 | 271 | |
| 4 | 2011 | 210 | |
| 5 | 2006 | 207 | |
| 6 | 2020 | 205 | |
| 7 | 2011 | 177 | |
| 8 | 1977 | 170 | |
| 9 | 2007 | 155 | |
| 10 | 2012 | 150 | |
| 11 | 2012 | 130 | |
| 12 | 2016 | 124 | |
| 13 | 1976 | 121 | |
| 14 | 2016 | 111 | |
| 15 | 2015 | 98 | |
| 16 | 2018 | 96 | |
| 17 | 2002 | 95 | |
| 18 | 2018 | 90 | |
| 19 | 2006 | 89 | |
| 20 | 2018 | 89 |
About Mark A. Schroeder
Mark A. Schroeder is a scholar working on Hematology, Genetics, Immunology, Oncology and Public Health, Environmental and Occupational Health, having authored 207 papers that have together received 7.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (54 papers), Acute Myeloid Leukemia Research (30 papers), Multiple Myeloma Research and Treatments (24 papers), Glioma Diagnosis and Treatment (23 papers), Immune Cell Function and Interaction (21 papers), Acute Lymphoblastic Leukemia research (18 papers), Chronic Myeloid Leukemia Treatments (12 papers) and T-cell and B-cell Immunology (12 papers). The work is most often cited by research in Genetics (1.5k citations), Hematology (1.4k citations), Oncology (1.7k citations), Immunology (1.1k citations) and Cancer Research (615 citations). Mark A. Schroeder has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Jann Nagina Sarkaria, Brett L. Carlson, John F. DiPersio, Mark S. Wrighton, Charles David James, Rolf D. Hubmayr, Nicholas E. Vlahakis, Evanthia Galanis, Caterina Giannini and Gaspar J. Kitange. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Clinical Cancer Research, Bone Marrow Transplantation and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.